The Subcuject WBI enables gentle injection of larger and more viscous doses compared to auto autoinjectors – at low cost
Biological drugs take up a high number of pharma development pipeline programs. The advantage of biological drugs is the specific targeting. Biologics are being developed for a large number of illnesses.
Biologics have to be injected, and in order to reduce the inconvenience, many drugs are being developed for subcutaneous delivery (as opposed to intravenous administration).
Furthermore, a large number of biologics are being developed for less frequent injection (e.g. weekly or monthly), resulting in larger and more viscous drugs needing to be administered. In order to avoid patients having go to hospitals for injections, it is also of benefit to the patients and to the total cost of health care if injections can be done at home.
The Subcuject WBI is a low cost device that allows for self-administration of larger doses in an easy-to-use and gentle way. The device is a prefilled, small, ready-to-use and noiseless device that is affixed to the skin, activated by a single button press and discarded after use. Needle insertion and retraction is invisible to the patient.